Necrobiosis lipoidica occurring in a patient with rheumatoid arthritis on concurrent tumor necrosis factor-α inhibitor therapy.
Department of Pathology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA.|Department of Dermatology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA.
Catherine G
CG
Chung
Department of Pathology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA.
Abric
A
Rosengrant
Department of Pathology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA.|Department of Dermatology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA.
Klaus F
KF
Helm
Department of Dermatology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA.
David L
DL
Shupp
D000068879:Adalimumab / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007868:Leg Dermatoses / Q000150:complications / Q000473:pathology*; D008727:Methotrexate / Q000627:therapeutic use; D009335:Necrobiosis Lipoidica / Q000150:complications* / Q000473:pathology*; D011241:Prednisone / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D055815:Young Adult
D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab; D011241:Prednisone; D008727:Methotrexate